Frederick L. Locke

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 40 papers. Top paper: “Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma”.

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Blood(2020)10.1182/blood.2019004710

N/A

2.8DataRank · unranked

99 citations

Haesook T. Kim, Caitlin Costello, Alex F. Herrera, Frederick L. Locke, Rodrigo Maegawa +20 more

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

New England Journal of Medicine(2017)10.1056/nejmoa1707447

N/A

1.3DataRank · unranked

5812 citations

Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson +41 more

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2020)10.1200/jco.19.02104

N/A

0.997DataRank · unranked

767 citations

Michael D. Jain, Lei Feng, Jay Y. Spiegel, Armin Ghobadi, Yi Lin +23 more

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0056

N/A

0.557DataRank · unranked

40 citations

Sae Bom Lee, Michael D. Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski +28 more

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

Cancer Medicine(2021)10.1002/cam4.3664

N/A

0DataRank · unranked

35 citations

Reena Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain +17 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.018

N/A

0DataRank · unranked

14 citations

Ariel Perez Perez, Christina A. Bachmeier, Rahul Mhaskar, Julio C. Chávez, Bijal Shah +7 more

American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.001

N/A

0DataRank · unranked

16 citations

Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W. Friedberg, Martin Dreyling +29 more

Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.014

N/A

0DataRank · unranked

10 citations

Mehdi Hamadani, Kwang Woo Ahn, Carlos Litovich, Guru Subramanian Guru Murthy, Frederick L. Locke +10 more

Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7552

N/A

0DataRank · unranked

13 citations

Frederick L. Locke, Zhen‐Huan Hu, Tanya Siddiqi, Sairah Ahmed, Armin Ghobadi +15 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more

The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis

Blood(2022)10.1182/blood.2022016194

N/A

0DataRank · unranked

88 citations

Michael Slade, Hagop M. Kantarjian, Julio Alvarenga, Ibrahim Aldoss, Kahee A. Mohammed +16 more

Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma

Blood(2022)10.1182/blood.2021015008

N/A

0DataRank · unranked

87 citations

Bachisio Ziccheddu, Caroline A. Coughlin, Rawan Faramand, Anthony J. Griswold, Kayla Reid +11 more

Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.023

N/A

0DataRank · unranked

44 citations

Anna Barata, Jennifer M. Logue, Anuhya Kommalapati, Kelly A. Hyland, Ashley M. Nelson +15 more

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

American Journal of Hematology(2023)10.1002/ajh.27056

N/A

0DataRank · unranked

48 citations

Yucai Wang, Omar Albanyan, Javier Muñoz, Pierre Sesques, Gloria Iacoboni +15 more

Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009426

N/A

0DataRank · unranked

29 citations

Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed Hossain, Michael D. Jain +5 more

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Blood Advances(2023)10.1182/bloodadvances.2023011489

N/A

0DataRank · unranked

26 citations

Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin +21 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Blood(2024)10.1182/blood.2024025945

N/A

0DataRank · unranked

130 citations

Krina K. Patel, Lauren C. Peres, Radhika Bansal, Mehmet H. Kocoglu, Leyla Shune +33 more

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0DataRank · unranked

74 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more

Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.09.013

N/A

0DataRank · unranked

4 citations

Anna Barata, Xiaoyin Li, Nathaly Irizarry‐Arroyo, Michael D. Jain, Taylor Welniak +19 more

ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.05.010

N/A

0DataRank · unranked

7 citations

Claire White, Magdi Elsallab, Stephanie Farnia, Ellen Fraint, Bambi Grilley +13 more

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy

American Journal of Hematology(2024)10.1002/ajh.27283

N/A

0DataRank · unranked

4 citations

Hailin Wang, Zhen‐Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson +18 more

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.11.15.623836

N/A

0DataRank · unranked

0 citations

Dhanvantri Chahar, Michael D. Jain, Alexandra M. Poos, Michael Durante, Bachisio Ziccheddu +19 more

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Blood(2025)10.1182/blood.2025028833

N/A

0DataRank · unranked

34 citations

Jaime Sanz, Teng Fei, Monica Nair, Hamza Hashmi, Abraham Avigdor +32 more

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009890

N/A

0DataRank · unranked

14 citations

Matthew J. Frigault, Michael Heim, S.R. Foley, Brian T. Hill, Grant Schofield +14 more

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Blood Advances(2025)10.1182/bloodadvances.2024014476

N/A

0DataRank · unranked

10 citations

Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel +21 more

Lymphoma accelerates T cell and tissue aging

Cancer Cell(2025)10.1016/j.ccell.2025.07.023

N/A

0DataRank · unranked

10 citations

Joshua Davis, Komal J Handoo, Aya G. Elmarsafawi, Anthony C. Augello, Chia‐Ho Cheng +21 more

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01338-1

N/A

0DataRank · unranked

8 citations

Sandeep Raj, Michael D. Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann +26 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011807

N/A

0DataRank · unranked

4 citations

Michael D. Jain, Meghan Menges, Ling Cen, Jerald Noble, Reginald Atkins +20 more

Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma

Cancer Cell(2025)10.1016/j.ccell.2025.09.007

N/A

0DataRank · unranked

4 citations

Francesca Albano, Annamaria Cesarano, Yunfei Wang, Brandon Kale, Kenneth H. Shain +19 more

Validation of Cure Assumptions when Analyzing ZUMA-7 Follow-up Data of Axicabtagene Ciloleucel and Standard of Care Therapy in Second-Line Relapsed/Refractory Large B-cell Lymphoma

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.09.015

N/A

0DataRank · unranked

3 citations

Olalekan O. Oluwole, Anik R. Patel, Markqayne D Ray, Yael Rodríguez‐Guadarrama, Nathaniel Smith +4 more

CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma

Research Square(2025)10.21203/rs.3.rs-3481746/v1

N/A

0DataRank · unranked

3 citations

Sae Bom Lee, Yun Pyo Kang, Justin C. Boucher, Jay K. Mandula, Emiliano Roselli +25 more

Racial and clinical determinants of response in 2304 large B-cell lymphomas treated with CD19 CAR T in clinical trials

Blood Advances(2025)10.1182/bloodadvances.2025016361

N/A

0DataRank · unranked

0 citations

Sheila S. Diamond, Pénélope Lafeuille, Jonathan H. Schatz, Francesco Maura, Jacob Aptekar +2 more

Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.12.025

N/A

0DataRank · unranked

10 citations

Ambuj Kumar, Hamza Hashmi, Franco Garcia, Constantine Logothetis, Alicia Darwin +14 more

Subjective cognition in chimeric antigen receptor T-cell therapy recipients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7020

N/A

0DataRank · unranked

1 citations

Aasha I. Hoogland, Kelly A. Hyland, Anuhya Kommalapati, Reena Jayani, Nathalie E. Irizarry-Arroyo +8 more

Reply

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.03.045

N/A

0DataRank · unranked

0 citations

Michael G. Fradley, Matthew J. Frigault, Frederick L. Locke, Tomas G. Neilan, Raza M. Alvi

Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.06.038

N/A

0DataRank · unranked

53 citations

Timothy J. Robinson, Austin J. Sim, Xuefeng Wang, Biwei Cao, Julio C. Chávez +11 more